KMT2A and neoplasm: Animals bearing xenograft tumors derived from Trx1- or TrxR1-depleted cells showed a significant decrease in tumor size and tumor weight following CHK1i treatment (Fig. 2e, f), leading to significant inhibition of tumor growth (Fig. 2g).